{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:22:12Z","timestamp":1793110932423,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xkme.2025.101076","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T20:12:05Z","timestamp":1754424725000},"page":"101076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Desensitization With Imlifidase: Overcoming Immunological Barriers in Kidney Transplantation"],"prefix":"10.1016","volume":"7","author":[{"given":"Paul Jos\u00e9","family":"Hern\u00e1ndez-Velasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Guti\u00e9rrez Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Polanco Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Esther","family":"Gonz\u00e1lez Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Mancebo Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amado","family":"Andr\u00e9s Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.xkme.2025.101076_bib1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/ajt.12786","article-title":"Quantifying the risk of incompatible kidney transplantation: a multicenter study","volume":"14","author":"Orandi","year":"2014","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2025.101076_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/TP.0000000000004824","article-title":"Improving the access of highly sensitized patients to kidney transplantation from deceased donors: the Spanish PATHI Program With Allocation Based on the Virtual Crossmatch","volume":"108","author":"Valentin","year":"2024","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.xkme.2025.101076_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15572","article-title":"A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor-specific anti HLA antibodies","volume":"103","author":"Garc\u00eda-Jim\u00e9nez","year":"2024","journal-title":"HLA"},{"issue":"8","key":"10.1016\/j.xkme.2025.101076_bib4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/life14080998","article-title":"Outcomes of kidney transplantation in highly hla-sensitized patients treated with intravenous immuno-globulin, plasmapheresis and rituximab: a meta-analysis","volume":"14","author":"Chandramohan","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.xkme.2025.101076_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11212","article-title":"Immunoadsorption- based hla desensitization in patients awaiting deceased donor kidney transplantation: an interventional, non-randomised, single cohort study","volume":"36","author":"Bureau","year":"2023","journal-title":"Transpl Int"},{"issue":"5","key":"10.1016\/j.xkme.2025.101076_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/tan.14781","article-title":"Clinical utility of serial serum dilutions for HLA antibody interpretation","volume":"100","author":"Tambur","year":"2022","journal-title":"HLA"},{"issue":"11","key":"10.1016\/j.xkme.2025.101076_bib7","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1111\/ajt.14733","article-title":"Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients","volume":"18","author":"Lorant","year":"2018","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.xkme.2025.101076_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132011","article-title":"Complete removal of extracellular IgG antibodies in a randomized dose-escalation phase I study with the bacterial enzyme IdeS \u2013 a novel therapeutic opportunity","volume":"10","author":"Winstedt","year":"2015","journal-title":"PLOS ONE"},{"issue":"8","key":"10.1016\/j.xkme.2025.101076_bib10","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/TP.0000000000003496","article-title":"Imlifidase desensitization in crossmatch-positive, highly sensitized kidney transplant recipients: results of an international phase 2 trial (Highdes)","volume":"105","author":"Jordan","year":"2021","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.xkme.2025.101076_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.xkme.2025.101076_bib12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/SLA.0000000000002924","article-title":"IdeS (imlifidase): a novel agent that cleaves human igg and permits successful kidney transplantation across high-strength donor-specific antibody","volume":"268","author":"Lonze","year":"2018","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.xkme.2025.101076_bib13","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1111\/ajt.16754","article-title":"Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients","volume":"21","author":"Kjellman","year":"2021","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2025.101076_bib14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ajt.2024.11.029","article-title":"Long-term outcomes at 5 years posttransplant in imlifidase-desensitized kidney transplant patients","volume":"25","author":"Jordan","year":"2025","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.xkme.2025.101076_bib15","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.ekir.2024.07.024","article-title":"Imlifidase in highly sensitized kidney transplant recipients with a positive crossmatch against a deceased donor","volume":"9","author":"Kamar","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.xkme.2025.101076_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11244","article-title":"Imlifidase for kidney transplantation of highly sensitized patients with a positive crossmatch: the French Consensus Guidelines","volume":"36","author":"Couzi","year":"2023","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.xkme.2025.101076_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2025.100919","article-title":"Spanish guidelines for kidney transplantation in highly sensitized patients with donor-specific anti-HLA antibodies","volume":"39","author":"Mancebo","year":"2025","journal-title":"Transplant Rev (Orlando)"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059525001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:15:27Z","timestamp":1759961727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059525001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2590059525001128"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101076","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Desensitization With Imlifidase: Overcoming Immunological Barriers in Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2025.101076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101076"}}